<html><body><h2>Case: 1016579</h2><h3> CDS Time: 1967-11-23</h3>
<patient name=1016579>
67.0 year old Asian_or_Pacific-Islander_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">67</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Calcium</td><td width="200">7</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">55</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">11</td><td width="200">1967-10-28</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Chloride</td><td width="200">102.0</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">35</td><td width="200">1967-9-28</td></tr>
<tr><td width="200">BUN</td><td width="200">23</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">HGB</td><td width="200">8</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">HCT</td><td width="200">26</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Sodium</td><td width="200">139</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Albumen</td><td width="200">2</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Creatinine</td><td width="200">5.8</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Weight</td><td width="200">170</td><td width="200">1967-9-28</td></tr>
<tr><td width="200">HbA1C</td><td width="200">7</td><td width="200">1967-9-29</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">7</td><td width="200">1967-9-29</td></tr>
<tr><td width="200">SGOT</td><td width="200">235</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Pulse</td><td width="200">88</td><td width="200">1967-9-28</td></tr>
<tr><td width="200">PLT</td><td width="200">309</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">WBC</td><td width="200">7</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">84</td><td width="200">1967-9-28</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1967-10-12</td></tr>
<tr><td width="200">SGPT</td><td width="200">152</td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1967-10-29</td></tr>
<tr><td width="200">CKD</td><td width="200"></td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1967-10-22</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1967-10-12</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1967-10-9</td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1967-10-1</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1967-10-29</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Nephritis_nephrosis_renal sclerosis</td><td width="200"></td><td width="200">1967-10-17</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1967-10-13</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1967-10-2</td></tr>
<tr><td width="200">Atrial_Tachycardia</td><td width="200"></td><td width="200">1967-9-28</td></tr>
<tr><td width="200">cardiac arrest</td><td width="200"></td><td width="200">1967-10-13</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) labetalol(60.0) hydralazine(0.0) Insulin(0.01) amiodarone(1.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1967-10-17</td>
<td width="200"> Nephritis_nephrosis_renal sclerosis()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-10-29</td>
<td width="200"> CKD()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-10-29</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-10-29</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1967-10-13</td>
<td width="200"> Liver_Disease()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1967-10-22</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1967-10-02</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-09-28</td>
<td width="200"> Atrial_Tachycardia()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-10-13</td>
<td width="200"> cardiac arrest()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1967-10-01</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1967-10-12</td>
<td width="200"> DM-Type2()</td></tr>
<tr> <td width="200"></td>
<td width="200">1967-10-09</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200">Creatinine > 1.5 and Male</td>
<td width="200"></td>
<td width="200"> Creatinine > 1.5 and Male[Creatinine(5.8/1967-10-29) && Sex(Male)]()</td></tr>
<tr><td width="200">Age>=65 and creatinine>=2</td>
<td width="200"></td>
<td width="200"> Age>=65 and creatinine>=2[Age(67.0/1970-1-1) && Creatinine(5.8/1967-10-29)]()</td></tr>
<tr><td width="200">Serum creatinine >=2</td>
<td width="200"></td>
<td width="200"> Serum creatinine >=2mg/dl[Creatinine(5.8/1967-10-29)]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1967-10-29</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA DM: Glycemic Control</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA DM: Glycemic Control: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(diabetes_mellitus)</i>]
<li>Creatinine > 1.5 and Male: [because <i> Creatinine > 1.5 and Male </i> evaluate to <b>true</b><i>(Creatinine(5.8/1967-10-29) && Sex(Male))</i>]
</ul>
<b>Scenario choice:</b> Insulin therapy only
<p>
<b>Goal:</b> HBA1C <= target(presence of target HBA1C)
<p><b>Reached goal?</b> failed(HbA1C(7.1/1967-9-29))
<p><b>Action Choices</b>
<ul>
<li><b>DM -  Insulin only</b><br>
<ul>
<li><b>Is patient high risk? If yes, refer <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])


<li><b>Metformin contraindicated, add Glipizide <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HbA1C > Target_HbA1c</i> evaluate to <b> true</b> because <i>HbA1C(7.1/1967-9-29)</i>)])
Add Glipizide
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>GLIPIZIDE(GLIPIZIDE)<ul><li>Relative indications:  DM-Type2(DM-Type2) <li>Sulfonylurea general info when prescribing(•	Efficacy ( HbA1c) a = 1.0 - 2.0 %
•	1st generation sulfonylureas are no longer commonly used.
•	No difference in long term efficacy or failure rate has been demonstrated among the sulfonylureas.
•	The preferred agents have shorter half-lives and inactive metabolites.
•	1st generation sulfonylureas are 100% renally eliminated. Chlorpropamide and tolazamide have active metabolites.
•	Glipizide, glyburide, and glimepiride are renally eliminated by 80 - 85%, 50%, and 60% respectively. All but glipizide have active metabolites.
•	Inexpensive)<li>preference: preferred</ul></ul></body></html>